Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  205.90
+4.75 (2.36%)
AAPL  265.17
+1.29 (0.49%)
AMD  202.31
-0.77 (-0.38%)
BAC  53.35
+0.61 (1.15%)
GOOG  304.64
+1.82 (0.60%)
META  640.68
+1.39 (0.22%)
MSFT  401.14
+4.28 (1.08%)
NVDA  188.99
+4.02 (2.17%)
ORCL  156.88
+2.91 (1.89%)
TSLA  415.30
+4.67 (1.14%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.